July 08, 2026

Optimized Formula: New Bio-Ink Can Depict the Cell Environment Even More Accurately

Optimized Formula: New Bio-Ink Can Depict the Cell Environment Even More Accurately

It should be biofunctional – that is, it should replicate the natural cellular environment as closely as possible – and it should be printable: bioink. Achieving both of these properties at the same time is an enormous challenge that conventional biomaterials often fail to meet. Together with two partner companies, researchers at the NMI have now taken an important step forward in 3D bioprinting.

Cells Have Specific Needs

For cells to survive – even outside the body – and thrive, they require very specific conditions. This is achieved through the right extracellular matrix, with which cells can interact effectively – a crucial factor in forming functional, tissue-like structures. The addition of cellulose nanofibrils mechanically stabilizes the bioink and makes it easy to print.

The researchers at NMI, Isabelle Schmidt and Hanna Hartmann, along with their colleagues at ibidi GmbH (experts in cell-based assays and cell microscopy) and the Swedish company Cellink (a leader in the development and manufacture of 3D bioprinters and bioinks), have jointly sought ways to optimize bioink so that the cells it contains are provided with the most suitable environment possible.

After numerous experiments and their evaluations, the project partners have now succeeded in identifying the right ingredients and their appropriate proportions – in other words, the recipe or formulation of the bioink.

Long-Term Goal: Active Ingredient Testing

What will these findings be used for? This bioink was developed as part of the BMFTR-funded Eurostars project PTube Chip. It represents an important step toward the long-term goal of using 3D bioprinting of human cells to create an in vitro model on which, for example, new drug candidates can be tested. However, there are still several more steps to take before this becomes a reality.

Paper: Schmidt et al., Controlling renal epithelial cell behavior by tuning the mechanical and biological characteristics of bioinks. Elsevier, 2026.

DOI: 10.1016/j.bioadv.2026.215036

Partner companies:

ibidi GmbH

Cellink

Our latest News

discover more
2026 BioTech Breakthrough Honors VectorBuilder With “Overall CGT Solution Provider of the Year”

2026 BioTech Breakthrough Honors VectorBuilder With “Overall CGT Solution Provider of the Year”

Annual awards program recognizes innovation in life sciences and biotechnology worldwide CHICAGO, November 5, 2026 – VectorBuilder, a global leader in gene delivery technologies, today announced it has been named “Overall CGT Solution Provider of the Year” in the sixth annual BioTech Breakthrough Awards, recognizing innovation across the global life sciences and biotechnology industries. VectorBuilder integrates vector […]

Breast Milk for the Youngest Babies: New Milk Bank at Heidelberg University Hospital

Breast Milk for the Youngest Babies: New Milk Bank at Heidelberg University Hospital

The Heidelberg University Hospital (UKHD) recently launched “HeidelMilk,” a breast milk donation bank. It provides premature infants with donated breast milk when their own mothers’ milk supply is insufficient. To mark World Prematurity Day on November 15, the UKHD is introducing this new service. Full Text in German below. Muttermilch für die Kleinsten: Neue Milchbank […]

When Brake Cells Become Killer Cells: Double Honor for DKFZ Researcher Julius Michel

When Brake Cells Become Killer Cells: Double Honor for DKFZ Researcher Julius Michel

Julius Michel, a postdoctoral researcher at the German Cancer Research Center (DKFZ), has received two awards: the Craig Tendler Award for Myeloma Research from the American Society of Hematology – awarded for the first time and accompanied by a $10,000 prize – as well as another award from the society. He has discovered that a […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp